Jackson et al v. Sanofi-Aventis U.S. LLC et al
Consolidated
Lead case: 9:20-md-02924
Lead case: 9:20-md-02924
| Florida Southern District Court | |
| Judge: | Robin L Rosenberg |
| Case #: | 9:20-cv-81349 |
| Nature of Suit | 365 Torts - Personal Injury - Product Liability |
| Cause | 28:1332 Diversity-Product Liability |
| Case Filed: | Aug 19, 2020 |
| Terminated: | Aug 20, 2020 |
| Case in other court: | Nebraska, 8:20-cv-00308 |
| Last checked: Monday Feb 15, 2021 4:22 AM EST |
|
Defendant
Boehringer Ingelheim Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Chattem Inc.
|
Represented By
|
|
Defendant
Pfizer Inc
|
Represented By
|
|
Defendant
Sanofi U.S. Services Inc.
|
Represented By
|
|
Defendant
Sanofi-Aventis U.S. LLC
|
Represented By
|
|
Plaintiff
Daniel Jackson
L08449 apalachee Correctional Institution 35 Apalachee Drive
Sneads, FL 32460 |
Represented By
|
|
Plaintiff
Karen Ellen Jackson, NE
|
Represented By
|
| Docket last updated: 11 hours ago |
| Tuesday, September 26, 2023 | ||
| 29 | 29
order
MDL 2924 Final Judgment
Tue 09/26 4:06 PM
RULE 58 FINAL JUDGMENT. Signed by Judge Robin L. Rosenberg on 9/26/2023. See attached document for full details. (jmd) |
|
| Thursday, April 14, 2022 | ||
| 24 | 24
cmp
Amended Complaint/Amended Notice of Removal
Thu 04/14 2:27 PM
Second AMENDED COMPLAINT Short-Form against All Defendants, filed by Karen Ellen Jackson, Daniel Jackson.(Domina, David) |
|
| Monday, March 01, 2021 | ||
| 23 | 23
8
pgs
cmp
MDL Amended Complaint
Mon 03/01 4:58 PM
First MDL AMENDED COMPLAINT Short-Form Complaint against Boehringer Ingelheim Pharmaceuticals Inc., Chattem Inc., Pfizer Inc, Sanofi U.S. Services Inc., Sanofi-Aventis U.S. LLC filed in response to Order Granting Motion for Leave, filed by Karen Ellen Jackson, Daniel Jackson.(Williams, Christian) |
|
| Thursday, January 14, 2021 | ||
| 22 | 22
cmp
Amended Complaint/Amended Notice of Removal
Thu 01/14 11:56 AM
Plaintiff's AMENDED COMPLAINT Short Form Complaint against All Defendants, filed by Karen Ellen Jackson, Daniel Jackson.(Williams, Christian) |
|
| Thursday, August 20, 2020 | ||
| 21 | 21
order
Administrative Order
Thu 08/20 4:23 PM
ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. Signed by Judge Robin L. Rosenberg on 8/20/2020. See attached document for full details. (mc) |
|
| 20 | 20
transfer
MDL Tag-Along/Transfer In Case Receipt
Thu 08/20 8:00 AM
MDL Transfer In Case Receipt from District of Nebraska. Case Number 8:20-cv-00308 with documents 1-17. Assigned FLSD Case Number 9:20-cv-81349-RLR on 8/19/2020. Re: FLSD MDL Case Number 9:20-md-02924-RLR. (mc) |
|
| Wednesday, August 19, 2020 | ||
| 19 | 19
order
Clerk's Notice of Judge Assignment and Optional Consent
Wed 08/19 3:40 PM
Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg. (mc) |
|
| 18 | 18
transfer
Case Transferred In - District Transfer - CV - NO FEE
Wed 08/19 3:38 PM
Case transferred in from Nebraska; Case Number 8:20-cv-00308. Electronic file including transfer order and docket sheet received. .(mc) |
|
| 17 | 17
order
MDL Conditional Transfer Order ~Util - Terminate Civil Case
Wed 08/19 1:15 PM
CERTIFIED COPY OF CONDITIONAL TRANSFER ORDER. Case is transferred to USDC-Southern District of Florida, Docket No. 2924. (TCL) |
|
|
Att: 1
Transmittal Letter
|
||
| 16 | 16
order
MDL Conditional Transfer Order
Wed 08/19 9:08 AM
COPY OF CONDITIONAL TRANSFER ORDER from the Multidistrict Litigation Panel. Clerk to wait for certified copy of order to transfer the file to USDC-Southern District of Florida, Docket No. 2924. (TCL) |
|
|
transfer
Case Transferred Out - District
Wed 08/19 1:21 PM
Case transferred to USDC-Southern District of Florida. Original electronic file sent. (TCL) |
||
| Tuesday, August 04, 2020 | ||
| 15 | 15
ORDER - IT IS ORDERED that Defendants' Agreed Motion to Stay (Filing No.3 ) is granted and all proceedings in this action are hereby stayed pending its transfer to MDL 2924. Ordered by Magistrate Judge Michael D. Nelson. (TCL)
|
|
| 14 | 14
LETTER by Clerk regarding Notice of Removal1 with copy of docket sheet to Multidistrict Litigation Panel Office. (LRM)
|
|
| 13 | 13 TEXT NOTICE REGARDING CORPORATE DISCLOSURE STATEMENT by Deputy Clerk as to Defendant Sanofi-Aventis U.S. LLC. Pursuant to Fed. R. Civ. P. 7.1, non-governmental corporate parties are required to file Corporate Disclosure Statements (Statements). The parties shall use the form Corporate Disclosure Statement, available on the Web site of the court at http://www.ned.uscourts.gov/forms/. If you have not filed your Statement, you must do so within 15 days of the date of this notice. If you have already filed your Statement in this case, you are reminded to file a Supplemental Statement within a reasonable time of any change in the information that the statement requires.(LRM) | |
| 12 | 12 TEXT NOTICE REGARDING CORPORATE DISCLOSURE STATEMENT by Deputy Clerk as to Defendant Sanofi US Services, Inc. Pursuant to Fed. R. Civ. P. 7.1, non-governmental corporate parties are required to file Corporate Disclosure Statements (Statements). The parties shall use the form Corporate Disclosure Statement, available on the Web site of the court at http://www.ned.uscourts.gov/forms/. If you have not filed your Statement, you must do so within 15 days of the date of this notice. If you have already filed your Statement in this case, you are reminded to file a Supplemental Statement within a reasonable time of any change in the information that the statement requires.(LRM) | |
| 11 | 11 TEXT NOTICE REGARDING CORPORATE DISCLOSURE STATEMENT by Deputy Clerk as to Defendant Pfizer Inc. Pursuant to Fed. R. Civ. P. 7.1, non-governmental corporate parties are required to file Corporate Disclosure Statements (Statements). The parties shall use the form Corporate Disclosure Statement, available on the Web site of the court at http://www.ned.uscourts.gov/forms/. If you have not filed your Statement, you must do so within 15 days of the date of this notice. If you have already filed your Statement in this case, you are reminded to file a Supplemental Statement within a reasonable time of any change in the information that the statement requires.(LRM) | |
| 10 | 10 TEXT NOTICE REGARDING CORPORATE DISCLOSURE STATEMENT by Deputy Clerk as to Defendant Chattem, Inc. Pursuant to Fed. R. Civ. P. 7.1, non-governmental corporate parties are required to file Corporate Disclosure Statements (Statements). The parties shall use the form Corporate Disclosure Statement, available on the Web site of the court at http://www.ned.uscourts.gov/forms/. If you have not filed your Statement, you must do so within 15 days of the date of this notice. If you have already filed your Statement in this case, you are reminded to file a Supplemental Statement within a reasonable time of any change in the information that the statement requires.(LRM) | |
| 9 | 9 TEXT NOTICE REGARDING CORPORATE DISCLOSURE STATEMENT by Deputy Clerk as to Defendant Boehringer Ingelheim Pharmaceuticals, Inc. Pursuant to Fed. R. Civ. P. 7.1, non-governmental corporate parties are required to file Corporate Disclosure Statements (Statements). The parties shall use the form Corporate Disclosure Statement, available on the Web site of the court at http://www.ned.uscourts.gov/forms/. If you have not filed your Statement, you must do so within 15 days of the date of this notice. If you have already filed your Statement in this case, you are reminded to file a Supplemental Statement within a reasonable time of any change in the information that the statement requires.(LRM) | |
| 8 | 8
ATTORNEY LETTER by Clerk that Attorney Joseph G. Petrosinelli has not registered for admittance to practice nor registered for the system. If the requested action is not taken within fifteen (15) days of the date of this letter, this matter will be referred to the assigned magistrate judge for the entry of a show cause order. (LRM)
|
|
| 7 | 7
ATTORNEY LETTER by Clerk that Attorney Robert B. Friedman has not registered for admittance to practice nor registered for the system. If the requested action is not taken within fifteen (15) days of the date of this letter, this matter will be referred to the assigned magistrate judge for the entry of a show cause order. (LRM)
|
|
| 6 | 6
ATTORNEY LETTER by Clerk that Attorney Julia Zousmer has not registered for admittance to practice nor registered for the system. If the requested action is not taken within fifteen (15) days of the date of this letter, this matter will be referred to the assigned magistrate judge for the entry of a show cause order. (LRM)
|
|
| 5 | 5
ATTORNEY LETTER by Clerk that Attorney Andrew T. Bayman has not registered for admittance to practice nor registered for the system. If the requested action is not taken within fifteen (15) days of the date of this letter, this matter will be referred to the assigned magistrate judge for the entry of a show cause order. (LRM)
|
|
| 4 | 4 TEXT NOTICE OF JUDGES ASSIGNED: Senior Judge Joseph F. Bataillon and Magistrate Judge Michael D. Nelson assigned. In accordance with 28 U.S.C. 636(c)(2), the parties are notified that, if all parties consent, a magistrate judge may conduct a civil action or proceeding, including a jury or nonjury trial, subject to the courts rules and policies governing the assignment of judges in civil cases. See Fed. R. Civ. P. 73; NEGenR 1.4. (LRM) | |
| Monday, August 03, 2020 | ||
| 3 | 3
UNOPPOSED MOTION to Stay by Attorney Michael K. Huffer on behalf of Defendants Boehringer Ingelheim Pharmaceuticals, Inc., Chattem, Inc., Pfizer Inc., Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC.(Huffer, Michael)
|
|
| 2 | 2
NOTICE of Request for Location of Trial by Attorney Michael K. Huffer on behalf of Defendants Boehringer Ingelheim Pharmaceuticals, Inc., Chattem, Inc., Pfizer Inc., Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC (Huffer, Michael)
|
|
| 1 | 1
NOTICE OF REMOVAL against All Plaintiffs from District Court of Madison County, Nebraska, Case number CI 20-0264 ( Filing fee $ 400, receipt number ANEDC-4210092) with attached state court pleadings, by Attorney Michael K. Huffer on behalf of Sanofi US Services, Inc., Chattem, Inc., Pfizer Inc., Sanofi-Aventis U.S. LLC, Boehringer Ingelheim Pharmaceuticals, Inc.(Huffer, Michael)
|
|
|
Att: 1
Exhibit 1,
|
||
|
Att: 2
Exhibit 2
|
||